Careers  |  Sign In  |  Register  |   Twitter

FDA Questions Safety and Efficacy of Antibacterial Soaps

The use of antibacterial soaps and other antibacterial products has skyrocketed in the past few decades but now the FDA is cracking down on companies who produce them, The New York Times reports. The proposed rule change is based on studies showing that the chemicals triclosan, found in liquid soaps, and triclocarban, found in bar soaps, can disrupt the development of the reproductive system and metabolism. The FDA has also stated that “there was no evidence that the substances were any more effective in preventing infection than plain soap and water.” The new proposed rule will not require companies to take their products off the market but will require companies to prove the safety and efficacy of their product within one year.

Read it in The New York Times.